| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | fucose binding | 3.55e-06 | 8 | 81 | 3 | GO:0042806 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 6.07e-05 | 430 | 81 | 9 | GO:0004175 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 1.23e-04 | 190 | 81 | 6 | GO:0004252 | |
| GeneOntologyMolecularFunction | D-mannose binding | 1.75e-04 | 27 | 81 | 3 | GO:0005537 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 1.96e-04 | 207 | 81 | 6 | GO:0008236 | |
| GeneOntologyMolecularFunction | calcium ion binding | EYS CELSR1 EFCAB6 HMCN1 DLL4 CUBN ADAM8 LTBP4 SVEP1 NOTCH2 NOTCH4 | 2.13e-04 | 749 | 81 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | serine hydrolase activity | 2.23e-04 | 212 | 81 | 6 | GO:0017171 | |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 3.37e-04 | 7 | 81 | 2 | GO:0005004 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 3.96e-04 | 85 | 81 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | frizzled binding | 6.59e-04 | 42 | 81 | 3 | GO:0005109 | |
| GeneOntologyMolecularFunction | integrin binding | 7.31e-04 | 175 | 81 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | peptidase activity | 1.31e-03 | 654 | 81 | 9 | GO:0008233 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 1.65e-03 | 15 | 81 | 2 | GO:0005005 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | ADAMTS12 RSPO3 SLC39A12 CELSR1 EGFR DLL4 WNT5A WNT6 SEMA5A SPAG6 NOTCH2 NOTCH4 EPHA4 | 9.43e-07 | 619 | 82 | 13 | GO:0002009 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | ADAMTS12 RSPO3 SLC39A12 CELSR1 EGFR DLL4 WNT5A WNT6 SEMA5A ADAM8 SPAG6 NOTCH2 NOTCH4 EPHA4 | 1.39e-06 | 750 | 82 | 14 | GO:0048729 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | ADAMTS12 SLC39A12 CELSR1 DLL4 WNT5A WNT6 SEMA5A NOTCH2 NOTCH4 EPHA4 | 6.51e-06 | 421 | 82 | 10 | GO:0060562 |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 4.31e-05 | 236 | 82 | 7 | GO:0061138 | |
| GeneOntologyBiologicalProcess | positive regulation of non-canonical Wnt signaling pathway | 4.73e-05 | 18 | 82 | 3 | GO:2000052 | |
| GeneOntologyBiologicalProcess | epithelium development | ADAMTS12 RSPO3 KRT2 SLC39A12 CELSR1 EGFR DLL4 WNT5A WNT6 ADAM7 SEMA5A PLAUR NSUN2 SPAG6 NOTCH2 NOTCH4 EPHA4 | 5.45e-05 | 1469 | 82 | 17 | GO:0060429 |
| GeneOntologyBiologicalProcess | regulation of establishment of planar polarity | 5.60e-05 | 19 | 82 | 3 | GO:0090175 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell apoptotic process | 5.60e-05 | 19 | 82 | 3 | GO:0070234 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 5.66e-05 | 103 | 82 | 5 | GO:2000628 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 6.78e-05 | 55 | 82 | 4 | GO:0060071 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 7.55e-05 | 258 | 82 | 7 | GO:0001763 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 1.12e-04 | 119 | 82 | 5 | GO:0010586 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte apoptotic process | 1.15e-04 | 24 | 82 | 3 | GO:0070230 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | ADAMTS12 RSPO3 SLC39A12 CELSR1 EGFR DLL4 WNT5A WNT6 SEMA5A C6 ADAM8 NOTCH2 NOTCH4 EPHA4 | 1.29e-04 | 1125 | 82 | 14 | GO:0035239 |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 1.39e-04 | 198 | 82 | 6 | GO:0048754 | |
| GeneOntologyBiologicalProcess | neuron projection fasciculation | 1.85e-04 | 28 | 82 | 3 | GO:0106030 | |
| GeneOntologyBiologicalProcess | axonal fasciculation | 1.85e-04 | 28 | 82 | 3 | GO:0007413 | |
| GeneOntologyBiologicalProcess | positive regulation of thymocyte apoptotic process | 2.32e-04 | 6 | 82 | 2 | GO:0070245 | |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway | 2.52e-04 | 77 | 82 | 4 | GO:0035567 | |
| GeneOntologyBiologicalProcess | regulation of non-canonical Wnt signaling pathway | 2.76e-04 | 32 | 82 | 3 | GO:2000050 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase C activity | 3.24e-04 | 7 | 82 | 2 | GO:1900020 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase C activity | 3.24e-04 | 7 | 82 | 2 | GO:1900019 | |
| GeneOntologyBiologicalProcess | cardiac atrium morphogenesis | 3.62e-04 | 35 | 82 | 3 | GO:0003209 | |
| GeneOntologyBiologicalProcess | substrate-dependent cell migration | 3.62e-04 | 35 | 82 | 3 | GO:0006929 | |
| GeneOntologyBiologicalProcess | tube development | ADAMTS12 RSPO3 SLC39A12 CELSR1 EGFR DLL4 WNT5A WNT6 ADAM7 SEMA5A C6 ADAM8 NOTCH2 NOTCH4 EPHA4 | 3.75e-04 | 1402 | 82 | 15 | GO:0035295 |
| GeneOntologyBiologicalProcess | cell fate commitment | 3.96e-04 | 338 | 82 | 7 | GO:0045165 | |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway | 4.20e-04 | 158 | 82 | 5 | GO:0030177 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte apoptotic process | 4.62e-04 | 38 | 82 | 3 | GO:2000108 | |
| GeneOntologyBiologicalProcess | pericardium morphogenesis | 5.52e-04 | 9 | 82 | 2 | GO:0003344 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.67e-04 | 656 | 83 | 10 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.74e-04 | 658 | 83 | 10 | GO:0030312 | |
| GeneOntologyCellularComponent | cell surface | VWF EGFR CLEC17A ASGR1 WNT5A WNT6 PLAUR CUBN ADAM8 VWDE NOTCH2 NOTCH4 EPHA4 | 4.16e-04 | 1111 | 83 | 13 | GO:0009986 |
| Domain | EGF | RSPO3 EYS CELSR1 FCGBP MALRD1 HMCN1 DLL4 CUBN ADAM8 LTBP4 VWDE SVEP1 NOTCH2 NOTCH4 | 1.46e-12 | 235 | 81 | 14 | SM00181 |
| Domain | EGF-like_dom | EYS CELSR1 FCGBP MALRD1 HMCN1 DLL4 C6 CUBN ADAM8 LTBP4 VWDE SVEP1 NOTCH2 NOTCH4 | 3.21e-12 | 249 | 81 | 14 | IPR000742 |
| Domain | EGF-like_CS | EYS CELSR1 MALRD1 HMCN1 DLL4 C6 CUBN ADAM8 LTBP4 VWDE SVEP1 NOTCH2 NOTCH4 EPHA8 | 6.05e-12 | 261 | 81 | 14 | IPR013032 |
| Domain | EGF_2 | EYS CELSR1 MALRD1 HMCN1 DLL4 C6 CUBN ADAM8 LTBP4 VWDE SVEP1 NOTCH2 NOTCH4 EPHA8 | 7.43e-12 | 265 | 81 | 14 | PS01186 |
| Domain | EGF_3 | EYS CELSR1 MALRD1 HMCN1 DLL4 C6 CUBN ADAM8 LTBP4 VWDE SVEP1 NOTCH2 NOTCH4 | 2.50e-11 | 235 | 81 | 13 | PS50026 |
| Domain | EGF_1 | EYS CELSR1 MALRD1 HMCN1 DLL4 C6 CUBN ADAM8 LTBP4 VWDE SVEP1 NOTCH2 NOTCH4 | 6.95e-11 | 255 | 81 | 13 | PS00022 |
| Domain | Growth_fac_rcpt_ | RSPO3 EYS CELSR1 HMCN1 EGFR DLL4 CUBN LTBP4 SVEP1 NOTCH2 NOTCH4 | 7.10e-11 | 156 | 81 | 11 | IPR009030 |
| Domain | ASX_HYDROXYL | 4.75e-10 | 100 | 81 | 9 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.04e-10 | 106 | 81 | 9 | IPR000152 | |
| Domain | EGF_CA | 2.82e-09 | 122 | 81 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.26e-09 | 124 | 81 | 9 | IPR001881 | |
| Domain | EGF | 3.76e-09 | 126 | 81 | 9 | PF00008 | |
| Domain | EGF_Ca-bd_CS | 2.08e-07 | 97 | 81 | 7 | IPR018097 | |
| Domain | EGF_CA | 2.39e-07 | 99 | 81 | 7 | PS01187 | |
| Domain | VWD | 5.74e-07 | 16 | 81 | 4 | SM00216 | |
| Domain | VWF_type-D | 5.74e-07 | 16 | 81 | 4 | IPR001846 | |
| Domain | VWFD | 5.74e-07 | 16 | 81 | 4 | PS51233 | |
| Domain | VWD | 5.74e-07 | 16 | 81 | 4 | PF00094 | |
| Domain | EGF_CA | 1.97e-06 | 86 | 81 | 6 | PF07645 | |
| Domain | hEGF | 6.21e-06 | 28 | 81 | 4 | PF12661 | |
| Domain | TSP_1 | 7.81e-06 | 63 | 81 | 5 | PF00090 | |
| Domain | TSP1 | 9.12e-06 | 65 | 81 | 5 | SM00209 | |
| Domain | TSP1_rpt | 9.12e-06 | 65 | 81 | 5 | IPR000884 | |
| Domain | TSP1 | 9.12e-06 | 65 | 81 | 5 | PS50092 | |
| Domain | TIL | 1.68e-05 | 12 | 81 | 3 | PF01826 | |
| Domain | C8 | 1.68e-05 | 12 | 81 | 3 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 2.18e-05 | 13 | 81 | 3 | IPR014853 | |
| Domain | C8 | 2.18e-05 | 13 | 81 | 3 | SM00832 | |
| Domain | LDLR_class-A_CS | 2.66e-05 | 40 | 81 | 4 | IPR023415 | |
| Domain | TIL_dom | 2.76e-05 | 14 | 81 | 3 | IPR002919 | |
| Domain | Ldl_recept_a | 4.27e-05 | 45 | 81 | 4 | PF00057 | |
| Domain | LDLRA_1 | 5.52e-05 | 48 | 81 | 4 | PS01209 | |
| Domain | LDLRA_2 | 6.00e-05 | 49 | 81 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 6.00e-05 | 49 | 81 | 4 | IPR002172 | |
| Domain | LDLa | 6.00e-05 | 49 | 81 | 4 | SM00192 | |
| Domain | VWC_out | 7.24e-05 | 19 | 81 | 3 | SM00215 | |
| Domain | TRYPSIN_SER | 9.74e-05 | 106 | 81 | 5 | PS00135 | |
| Domain | TRYPSIN_HIS | 1.02e-04 | 107 | 81 | 5 | PS00134 | |
| Domain | FacI_MAC | 1.11e-04 | 4 | 81 | 2 | IPR003884 | |
| Domain | Notch | 1.11e-04 | 4 | 81 | 2 | IPR008297 | |
| Domain | NODP | 1.11e-04 | 4 | 81 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 1.11e-04 | 4 | 81 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 1.11e-04 | 4 | 81 | 2 | IPR010660 | |
| Domain | NOD | 1.11e-04 | 4 | 81 | 2 | PF06816 | |
| Domain | FIMAC | 1.11e-04 | 4 | 81 | 2 | SM00057 | |
| Domain | NOD | 1.11e-04 | 4 | 81 | 2 | SM01338 | |
| Domain | NODP | 1.11e-04 | 4 | 81 | 2 | SM01339 | |
| Domain | Peptidase_S1A | 1.32e-04 | 113 | 81 | 5 | IPR001314 | |
| Domain | TRYPSIN_DOM | 1.43e-04 | 115 | 81 | 5 | PS50240 | |
| Domain | Tryp_SPc | 1.55e-04 | 117 | 81 | 5 | SM00020 | |
| Domain | Ephrin_rec_like | 1.69e-04 | 25 | 81 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.69e-04 | 25 | 81 | 3 | IPR011641 | |
| Domain | Trypsin | 1.82e-04 | 121 | 81 | 5 | PF00089 | |
| Domain | Trypsin_dom | 1.82e-04 | 121 | 81 | 5 | IPR001254 | |
| Domain | LNR | 1.84e-04 | 5 | 81 | 2 | PS50258 | |
| Domain | Peptidase_S1_PA | 1.96e-04 | 123 | 81 | 5 | IPR009003 | |
| Domain | Notch_dom | 3.85e-04 | 7 | 81 | 2 | IPR000800 | |
| Domain | Notch | 3.85e-04 | 7 | 81 | 2 | PF00066 | |
| Domain | NL | 3.85e-04 | 7 | 81 | 2 | SM00004 | |
| Domain | Peptidase_M12B_N | 6.42e-04 | 39 | 81 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 6.42e-04 | 39 | 81 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 6.92e-04 | 40 | 81 | 3 | PS00427 | |
| Domain | Reprolysin | 6.92e-04 | 40 | 81 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 6.92e-04 | 40 | 81 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 6.92e-04 | 40 | 81 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 6.92e-04 | 40 | 81 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 7.44e-04 | 41 | 81 | 3 | IPR001762 | |
| Domain | ANK | 7.76e-04 | 251 | 81 | 6 | SM00248 | |
| Domain | VWF_dom | 7.99e-04 | 42 | 81 | 3 | IPR001007 | |
| Domain | ANK_REPEAT | 8.09e-04 | 253 | 81 | 6 | PS50088 | |
| Domain | ANK_REP_REGION | 8.26e-04 | 254 | 81 | 6 | PS50297 | |
| Domain | Ankyrin_rpt | 9.70e-04 | 262 | 81 | 6 | IPR002110 | |
| Domain | - | 9.96e-04 | 11 | 81 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 9.96e-04 | 11 | 81 | 2 | IPR023413 | |
| Domain | - | 1.04e-03 | 46 | 81 | 3 | 4.10.400.10 | |
| Domain | TRYPSIN_HIS | 1.05e-03 | 103 | 81 | 4 | IPR018114 | |
| Domain | CUB | 1.25e-03 | 49 | 81 | 3 | PF00431 | |
| Domain | KAZAL_2 | 1.33e-03 | 50 | 81 | 3 | PS51465 | |
| Domain | CUB | 1.33e-03 | 50 | 81 | 3 | SM00042 | |
| Domain | Kazal_dom | 1.41e-03 | 51 | 81 | 3 | IPR002350 | |
| Domain | CUB | 1.57e-03 | 53 | 81 | 3 | PS01180 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 1.63e-03 | 14 | 81 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 1.63e-03 | 14 | 81 | 2 | PS00790 | |
| Domain | Eph_TM | 1.63e-03 | 14 | 81 | 2 | IPR027936 | |
| Domain | Tyr_kinase_rcpt_V_CS | 1.63e-03 | 14 | 81 | 2 | IPR001426 | |
| Domain | EPH_lbd | 1.63e-03 | 14 | 81 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 1.63e-03 | 14 | 81 | 2 | PF01404 | |
| Domain | EphA2_TM | 1.63e-03 | 14 | 81 | 2 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 1.63e-03 | 14 | 81 | 2 | IPR016257 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 1.63e-03 | 14 | 81 | 2 | IPR001090 | |
| Domain | EPH_LBD | 1.63e-03 | 14 | 81 | 2 | PS51550 | |
| Domain | CUB_dom | 1.94e-03 | 57 | 81 | 3 | IPR000859 | |
| Domain | Disintegrin_CS | 2.14e-03 | 16 | 81 | 2 | IPR018358 | |
| Domain | EGF_extracell | 2.25e-03 | 60 | 81 | 3 | IPR013111 | |
| Domain | EGF_2 | 2.25e-03 | 60 | 81 | 3 | PF07974 | |
| Domain | MAM | 2.42e-03 | 17 | 81 | 2 | SM00137 | |
| Domain | Ank_2 | 2.43e-03 | 215 | 81 | 5 | PF12796 | |
| Domain | ConA-like_dom | 2.63e-03 | 219 | 81 | 5 | IPR013320 | |
| Domain | MAM | 2.72e-03 | 18 | 81 | 2 | PF00629 | |
| Domain | MAM_dom | 2.72e-03 | 18 | 81 | 2 | IPR000998 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.92e-06 | 68 | 54 | 5 | M27303 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 6.37e-06 | 69 | 54 | 5 | M16894 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.48e-05 | 13 | 54 | 3 | M47423 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 2.58e-05 | 154 | 54 | 6 | M39739 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 7.00e-05 | 58 | 54 | 4 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 7.49e-05 | 59 | 54 | 4 | M48343 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 8.60e-05 | 118 | 54 | 5 | M39852 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 1.02e-04 | 24 | 54 | 3 | M11190 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 1.43e-04 | 5 | 54 | 2 | M27411 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.46e-04 | 27 | 54 | 3 | M39545 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.12e-04 | 143 | 54 | 5 | M27275 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 2.14e-04 | 6 | 54 | 2 | M27068 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 2.70e-04 | 82 | 54 | 4 | MM15922 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 3.68e-04 | 161 | 54 | 5 | M39770 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.71e-04 | 250 | 54 | 6 | M27554 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 4.40e-04 | 39 | 54 | 3 | MM14604 | |
| Pathway | WP_CANCER_PATHWAYS | 6.42e-04 | 507 | 54 | 8 | M48302 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 6.73e-04 | 45 | 54 | 3 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 7.18e-04 | 46 | 54 | 3 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 7.65e-04 | 47 | 54 | 3 | M7946 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 7.75e-04 | 11 | 54 | 2 | M47865 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 7.75e-04 | 11 | 54 | 2 | M27882 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 9.27e-04 | 12 | 54 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 9.27e-04 | 12 | 54 | 2 | M47533 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.09e-03 | 13 | 54 | 2 | M47534 | |
| Pathway | PID_NOTCH_PATHWAY | 1.48e-03 | 59 | 54 | 3 | M17 | |
| Pathway | WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME | 1.53e-03 | 130 | 54 | 4 | M39787 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.63e-03 | 61 | 54 | 3 | M39540 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.67e-03 | 16 | 54 | 2 | M47424 | |
| Pubmed | Expression patterns of Notch receptors and their ligands Jagged and Delta in human placenta. | 1.31e-07 | 5 | 83 | 3 | 21726900 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 23675950 | ||
| Pubmed | 1.75e-07 | 21 | 83 | 4 | 28656980 | ||
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 12475935 | ||
| Pubmed | 1.04e-06 | 75 | 83 | 5 | 20637190 | ||
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 16245338 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 1.55e-06 | 10 | 83 | 3 | 23665443 | |
| Pubmed | 2.13e-06 | 11 | 83 | 3 | 19210786 | ||
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 2.13e-06 | 11 | 83 | 3 | 9187150 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 2.35e-06 | 358 | 83 | 8 | 32460013 | |
| Pubmed | 2.84e-06 | 12 | 83 | 3 | 15465494 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 3.68e-06 | 13 | 83 | 3 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 3.68e-06 | 13 | 83 | 3 | 20558824 | |
| Pubmed | 4.68e-06 | 14 | 83 | 3 | 14757642 | ||
| Pubmed | 5.42e-06 | 48 | 83 | 4 | 35247391 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11532344 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12604671 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30611716 | ||
| Pubmed | Rare genetic variants in Tunisian Jewish patients suffering from age-related macular degeneration. | 5.63e-06 | 2 | 83 | 2 | 25986072 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12814948 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18710625 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21045140 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12203726 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25837250 | ||
| Pubmed | Asialoglycoprotein receptor promotes cancer metastasis by activating the EGFR-ERK pathway. | 5.63e-06 | 2 | 83 | 2 | 21868757 | |
| Pubmed | A relative signalling model for the formation of a topographic neural map. | 5.63e-06 | 2 | 83 | 2 | 15483613 | |
| Pubmed | Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR. | 5.63e-06 | 2 | 83 | 2 | 28193671 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15302576 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 23587900 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21896743 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20643108 | ||
| Pubmed | 5.84e-06 | 15 | 83 | 3 | 12971992 | ||
| Pubmed | Control of spinal motor neuron terminal differentiation through sustained Hoxc8 gene activity. | 5.89e-06 | 49 | 83 | 4 | 35315772 | |
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 7.18e-06 | 16 | 83 | 3 | 12617809 | |
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 10585256 | ||
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 17273555 | ||
| Pubmed | 8.70e-06 | 17 | 83 | 3 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 8.70e-06 | 17 | 83 | 3 | 15821257 | |
| Pubmed | 8.70e-06 | 17 | 83 | 3 | 39315665 | ||
| Pubmed | 1.04e-05 | 18 | 83 | 3 | 18093989 | ||
| Pubmed | 1.04e-05 | 18 | 83 | 3 | 15689374 | ||
| Pubmed | 1.24e-05 | 19 | 83 | 3 | 16518823 | ||
| Pubmed | Differential Islet-1 expression among lumbosacral spinal motor neurons in prenatal mouse. | 1.69e-05 | 3 | 83 | 2 | 19236857 | |
| Pubmed | Genetic dissection of EphA receptor signaling dynamics during retinotopic mapping. | 1.69e-05 | 3 | 83 | 2 | 21753007 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 23015403 | ||
| Pubmed | Differential expression of Notch genes in human osteoblastic cells. | 1.69e-05 | 3 | 83 | 2 | 11836628 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 8163572 | ||
| Pubmed | KLF13 restrains Dll4-muscular Notch2 axis to improve the muscle atrophy. | 1.69e-05 | 3 | 83 | 2 | 38973459 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 29282218 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 11823422 | ||
| Pubmed | Islet-1 expression in thoracic spinal motor neurons in prenatal mouse. | 1.69e-05 | 3 | 83 | 2 | 21651972 | |
| Pubmed | Notch signaling: cell fate control and signal integration in development. | 1.69e-05 | 3 | 83 | 2 | 10221902 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 28572448 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 26255671 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 26472724 | ||
| Pubmed | Helicobacter pylori Infection of Gastric Epithelial Cells Affects NOTCH Pathway In Vitro. | 1.69e-05 | 3 | 83 | 2 | 27073072 | |
| Pubmed | D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR. | 1.69e-05 | 3 | 83 | 2 | 29184982 | |
| Pubmed | Factor XII and uPAR upregulate neutrophil functions to influence wound healing. | 1.69e-05 | 3 | 83 | 2 | 29376892 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 33351914 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 38063205 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 23777652 | ||
| Pubmed | Delta-like 4/Notch pathway is differentially regulated in benign and malignant thyroid tissues. | 1.69e-05 | 3 | 83 | 2 | 22066479 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 26360782 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 30061574 | ||
| Pubmed | [Estimation of the diagnostic potential of APOD, PTOV1, and EPHA4 for prostatic neoplasms]. | 1.69e-05 | 3 | 83 | 2 | 27804940 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 16951162 | ||
| Pubmed | Stem cell function and stress response are controlled by protein synthesis. | 1.69e-05 | 3 | 83 | 2 | 27306184 | |
| Pubmed | Endothelial PlexinD1 signaling instructs spinal cord vascularization and motor neuron development. | 1.95e-05 | 22 | 83 | 3 | 36549270 | |
| Pubmed | 2.24e-05 | 23 | 83 | 3 | 14701881 | ||
| Pubmed | 2.24e-05 | 23 | 83 | 3 | 36239412 | ||
| Pubmed | 2.24e-05 | 23 | 83 | 3 | 31226309 | ||
| Pubmed | 2.56e-05 | 24 | 83 | 3 | 21633169 | ||
| Pubmed | 2.90e-05 | 25 | 83 | 3 | 37869988 | ||
| Pubmed | 2.90e-05 | 25 | 83 | 3 | 21786021 | ||
| Pubmed | 3.16e-05 | 251 | 83 | 6 | 29031500 | ||
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 3.27e-05 | 26 | 83 | 3 | 19369401 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 24145721 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 20069356 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 3.37e-05 | 4 | 83 | 2 | 19404845 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 28669409 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 22984561 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 26000482 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 11401408 | ||
| Pubmed | Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands. | 3.37e-05 | 4 | 83 | 2 | 28319044 | |
| Pubmed | Functional conservation of mouse Notch receptor family members. | 3.37e-05 | 4 | 83 | 2 | 8898100 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 36376768 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 23444212 | ||
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 3.37e-05 | 4 | 83 | 2 | 17920003 | |
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 3.37e-05 | 4 | 83 | 2 | 28061457 | |
| Pubmed | Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2. | 3.37e-05 | 4 | 83 | 2 | 32820046 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 11466531 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 25959774 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 24151014 | ||
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 3.37e-05 | 4 | 83 | 2 | 10194420 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 34564708 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 38462037 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 11459941 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 21391216 | ||
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 3.37e-05 | 4 | 83 | 2 | 18184405 | |
| Pubmed | Notch signaling in the mammalian central nervous system: insights from mouse mutants. | 3.37e-05 | 4 | 83 | 2 | 15917835 | |
| Interaction | POTED interactions | 2.59e-07 | 4 | 82 | 3 | int:POTED | |
| Interaction | NOTCH4 interactions | 1.45e-06 | 21 | 82 | 4 | int:NOTCH4 | |
| Interaction | POTEC interactions | 1.80e-05 | 13 | 82 | 3 | int:POTEC | |
| Cytoband | 10p12.31 | 7.46e-04 | 22 | 84 | 2 | 10p12.31 | |
| Cytoband | 19q13 | 1.49e-03 | 31 | 84 | 2 | 19q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p13 | 2.16e-03 | 139 | 84 | 3 | chr5p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p12 | 2.21e-03 | 140 | 84 | 3 | chr10p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 3.22e-03 | 330 | 84 | 4 | chr22q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 3.63e-03 | 167 | 84 | 3 | chr1q25 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 8.25e-04 | 13 | 60 | 2 | 685 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 9.61e-04 | 14 | 60 | 2 | 1095 | |
| GeneFamily | Ankyrin repeat domain containing | 1.24e-03 | 242 | 60 | 5 | 403 | |
| GeneFamily | Wnt family|Endogenous ligands | 1.79e-03 | 19 | 60 | 2 | 360 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.60e-03 | 27 | 60 | 2 | 47 | |
| Coexpression | NABA_MATRISOME | ADAMTS12 RSPO3 EYS TMPRSS15 VWF HMCN1 CLEC17A WNT5A WNT6 ADAM7 SEMA5A ADAM8 LTBP4 MUC6 VWDE SVEP1 | 1.42e-07 | 1026 | 84 | 16 | M5889 |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 9.58e-07 | 163 | 84 | 7 | M12112 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.27e-06 | 196 | 84 | 7 | M3008 | |
| Coexpression | NABA_MATRISOME | ADAMTS12 RSPO3 TMPRSS15 VWF HMCN1 WNT5A WNT6 ADAM7 SEMA5A ADAM8 LTBP4 MUC6 VWDE SVEP1 | 3.65e-06 | 1008 | 84 | 14 | MM17056 |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.73e-05 | 16 | 84 | 3 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.73e-05 | 16 | 84 | 3 | M2207 | |
| Coexpression | NABA_CORE_MATRISOME | 2.95e-05 | 275 | 84 | 7 | M5884 | |
| Coexpression | HEVNER_CORTEX_VASCULAR_ENDOTHELIAL_CELLS | 2.96e-05 | 19 | 84 | 3 | MM420 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.51e-05 | 191 | 84 | 6 | MM17059 | |
| Coexpression | GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN | 4.54e-05 | 200 | 84 | 6 | M3047 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.38e-08 | 186 | 84 | 7 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.38e-08 | 190 | 84 | 7 | 3b9abc25b17e7295356ded57ff2ca519fa9f2686 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 8.51e-08 | 194 | 84 | 7 | eaeeb84576270cc3fc59002ba33bff9639bb0b02 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-06 | 184 | 84 | 6 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-06 | 186 | 84 | 6 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-06 | 186 | 84 | 6 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.52e-06 | 188 | 84 | 6 | 50b27fc12347ca16bd62333baf345c83cb422a8f | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-06 | 191 | 84 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 191 | 84 | 6 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.00e-06 | 197 | 84 | 6 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.06e-06 | 198 | 84 | 6 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.06e-06 | 198 | 84 | 6 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-06 | 119 | 84 | 5 | c3f1223356e7f245a460ea5568a223e34e458dc1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.89e-06 | 144 | 84 | 5 | 0322fef818a963be00535d5f141f028d43de5c6a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-05 | 153 | 84 | 5 | edf5d026e8e4c685b7c369d70894741bb2cd568e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-05 | 153 | 84 | 5 | 3240d4d690335ba22317b1f3d33f9ea069e93838 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.13e-05 | 155 | 84 | 5 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 158 | 84 | 5 | ba9998cbf786c515d30fe42de02c7a246db1b6f9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 158 | 84 | 5 | a2efcc184ef13d81373e3690253ba35f6be09c5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 158 | 84 | 5 | e52eff2bd1e7e0ce9c278ed5109802865e0fe69c | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 162 | 84 | 5 | 22f1abd20f43bc7e7fc46969da9962faf70ae5d2 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 162 | 84 | 5 | 966df4558140c3d541999ab553f201ae76a1c401 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.48e-05 | 164 | 84 | 5 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 167 | 84 | 5 | a4a795751644b22af616335379e64ae95175180c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.76e-05 | 170 | 84 | 5 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.81e-05 | 171 | 84 | 5 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.08e-05 | 176 | 84 | 5 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 176 | 84 | 5 | 057d2759fdc67176c25802b57a78064d8cc93205 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 176 | 84 | 5 | b81e5d23b31cefc8d374ef403e21acc390c14a80 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.08e-05 | 176 | 84 | 5 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-05 | 177 | 84 | 5 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.14e-05 | 177 | 84 | 5 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.14e-05 | 177 | 84 | 5 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 178 | 84 | 5 | 09d2687e0d79f12e90af35fc1c0453d249cf2d19 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-basal_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.20e-05 | 178 | 84 | 5 | 03f22485074b3cbf9a6ad4d543c5bbfa826dc741 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 179 | 84 | 5 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-05 | 180 | 84 | 5 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 180 | 84 | 5 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 180 | 84 | 5 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-05 | 180 | 84 | 5 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-05 | 180 | 84 | 5 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-05 | 181 | 84 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 2.38e-05 | 181 | 84 | 5 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.44e-05 | 182 | 84 | 5 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.44e-05 | 182 | 84 | 5 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.44e-05 | 182 | 84 | 5 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.51e-05 | 183 | 84 | 5 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 183 | 84 | 5 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-05 | 183 | 84 | 5 | 858682df5592c6856487487a7baabd6e60e63a38 | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 2.51e-05 | 183 | 84 | 5 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-05 | 183 | 84 | 5 | f8212bf8a8b8312434ae030261c558c147f61747 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 183 | 84 | 5 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.57e-05 | 184 | 84 | 5 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.57e-05 | 184 | 84 | 5 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 186 | 84 | 5 | 5d0cd07b6b51e8ce9e1da949f757dc4575ec5752 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.71e-05 | 186 | 84 | 5 | b80aaeebc03a318052076d2f02c123f5ddc5e73a | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.71e-05 | 186 | 84 | 5 | 9c7924875f70420720149287c500b4dfa8d24673 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-05 | 186 | 84 | 5 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.71e-05 | 186 | 84 | 5 | 8a8ed1502542d4895cba3fd5d534256206578716 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 2.71e-05 | 186 | 84 | 5 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-05 | 187 | 84 | 5 | 12129e02638c20d9b7c1c6e512d48bfd966e1029 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-05 | 187 | 84 | 5 | 83930ef55191eff9006113feaeabb3c2fa21fd05 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 188 | 84 | 5 | a6ed43fdd42d681c9fbb2fb368947ab7e41d8d7c | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 188 | 84 | 5 | 54550313db78b3b5b572fa1e67092c8f6f33aab5 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 188 | 84 | 5 | 405efea75233ecf70f7d19b630230798d817b7f2 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma-3|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.91e-05 | 93 | 84 | 4 | be5bd6d0a1d23c9aca6436c247ed173d009e7623 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-05 | 189 | 84 | 5 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.93e-05 | 189 | 84 | 5 | 2e43428f1ef9683c6f8c9897d46aa7d34bf9047f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 190 | 84 | 5 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.00e-05 | 190 | 84 | 5 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-05 | 190 | 84 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.08e-05 | 191 | 84 | 5 | f5ce33af56178333730be308253943c54a0724cf | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.08e-05 | 191 | 84 | 5 | 6e6b2cb390cc5cd0356924a2c36fbe5b5bd5966c | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.08e-05 | 191 | 84 | 5 | 482db995930346be69072ace2fd78fd453e97fb5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 192 | 84 | 5 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-05 | 192 | 84 | 5 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG-26|World / Primary Cells by Cluster | 3.16e-05 | 192 | 84 | 5 | b8cf9c3c6b954e93f7504d214e39662bfa8f96f5 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-05 | 192 | 84 | 5 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-05 | 192 | 84 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 192 | 84 | 5 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-05 | 192 | 84 | 5 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG-34|World / Primary Cells by Cluster | 3.23e-05 | 193 | 84 | 5 | d55f792eb3db10452347681131e07e041348fd89 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.23e-05 | 193 | 84 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 193 | 84 | 5 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.32e-05 | 194 | 84 | 5 | 7c6c0376603e5fcb64814fd6204d153629c2fbf5 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 3.32e-05 | 194 | 84 | 5 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.32e-05 | 194 | 84 | 5 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 3.32e-05 | 194 | 84 | 5 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-05 | 194 | 84 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG|World / Primary Cells by Cluster | 3.32e-05 | 194 | 84 | 5 | 3a4bf6a7fac0e5bdbb4bb17041806d06a75974d9 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 3.40e-05 | 195 | 84 | 5 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 195 | 84 | 5 | d32716a12014522492becbde1088dc1106308490 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 195 | 84 | 5 | b913d5df50c88a3a255f516a1aa42419c6701e1e | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.48e-05 | 196 | 84 | 5 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 3.48e-05 | 196 | 84 | 5 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 196 | 84 | 5 | 7d5eaed189aa6116f3799be010139fb675ec65e0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-05 | 196 | 84 | 5 | a20a56d8997d6db2a10046c8801c619a379de83c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.48e-05 | 196 | 84 | 5 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | Control-Stromal-Fibroblast|Control / Disease state, Lineage and Cell class | 3.48e-05 | 196 | 84 | 5 | 7ca94477498a84cafcdd9933ee92a6cbde76c70e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.48e-05 | 196 | 84 | 5 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| Drug | AC1NRA23 | 6.64e-06 | 73 | 82 | 5 | CID005287657 | |
| Drug | Methacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 7.17e-06 | 197 | 82 | 7 | 4143_UP | |
| Disease | Hereditary Diffuse Gastric Cancer | 1.22e-06 | 293 | 79 | 8 | C1708349 | |
| Disease | Stomach Neoplasms | 1.35e-06 | 297 | 79 | 8 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.45e-06 | 300 | 79 | 8 | C0024623 | |
| Disease | Malignant neoplasm of breast | RSPO3 SLC39A12 KLK10 VWF EGFR DLL4 SREBF2 CUBN SPAG6 RXRB NOTCH2 NOTCH4 | 2.75e-05 | 1074 | 79 | 12 | C0006142 |
| Disease | hemangioblastoma (is_marker_for) | 4.23e-05 | 4 | 79 | 2 | DOID:5241 (is_marker_for) | |
| Disease | Mammary Carcinoma, Human | 8.21e-05 | 525 | 79 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 8.21e-05 | 525 | 79 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 8.43e-05 | 527 | 79 | 8 | C1458155 | |
| Disease | Breast Carcinoma | 9.72e-05 | 538 | 79 | 8 | C0678222 | |
| Disease | cervical cancer | 1.04e-04 | 34 | 79 | 3 | C4048328 | |
| Disease | Uterine Cervical Neoplasm | 1.14e-04 | 35 | 79 | 3 | C0007873 | |
| Disease | vitamin supplement exposure measurement, Cleft palate, cleft lip, parental genotype effect measurement | 1.96e-04 | 8 | 79 | 2 | EFO_0003959, EFO_0005939, EFO_0009116, HP_0000175 | |
| Disease | hemangiopericytoma (is_marker_for) | 2.52e-04 | 9 | 79 | 2 | DOID:264 (is_marker_for) | |
| Disease | diabetic retinopathy (is_marker_for) | 4.15e-04 | 54 | 79 | 3 | DOID:8947 (is_marker_for) | |
| Disease | age at diagnosis, type 1 diabetes mellitus | 6.23e-04 | 62 | 79 | 3 | EFO_0004918, MONDO_0005147 | |
| Disease | urokinase plasminogen activator surface receptor measurement | 6.31e-04 | 14 | 79 | 2 | EFO_0010932 | |
| Disease | Proteinuria | 7.27e-04 | 15 | 79 | 2 | HP_0000093 | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 7.27e-04 | 15 | 79 | 2 | C2930967 | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 8.29e-04 | 16 | 79 | 2 | EFO_0004569, MONDO_0009354 | |
| Disease | glomerulonephritis (implicated_via_orthology) | 9.38e-04 | 17 | 79 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | Disease Exacerbation | 1.02e-03 | 165 | 79 | 4 | C0235874 | |
| Disease | Age-related macular degeneration | 1.05e-03 | 18 | 79 | 2 | cv:C0242383 | |
| Disease | Carcinoma of bladder | 1.05e-03 | 18 | 79 | 2 | C0699885 | |
| Disease | type 1 diabetes mellitus (biomarker_via_orthology) | 1.18e-03 | 19 | 79 | 2 | DOID:9744 (biomarker_via_orthology) | |
| Disease | Glioblastoma | 1.26e-03 | 79 | 79 | 3 | C0017636 | |
| Disease | blood aluminium measurement | 1.30e-03 | 20 | 79 | 2 | EFO_0007575 | |
| Disease | Infiltrating duct carcinoma of female breast | 1.44e-03 | 21 | 79 | 2 | C3165106 | |
| Disease | Giant Cell Glioblastoma | 1.51e-03 | 84 | 79 | 3 | C0334588 | |
| Disease | remission, hepatitis C virus infection | 1.73e-03 | 23 | 79 | 2 | EFO_0003047, EFO_0009785 | |
| Disease | unipolar depression, neuroticism measurement | 1.88e-03 | 24 | 79 | 2 | EFO_0003761, EFO_0007660 | |
| Disease | chronic obstructive pulmonary disease (biomarker_via_orthology) | 2.56e-03 | 28 | 79 | 2 | DOID:3083 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MAALQGNGSERTCCP | 141 | P07306 | |
| VGMGNGTPCSLKQNR | 191 | Q96DZ1 | |
| CQKGGCRSEPIQMEN | 351 | P30411 | |
| CKGDSGGPLVCMDAN | 521 | P05156 | |
| CQGDSGGPLMCKDSK | 236 | P10323 | |
| SGTKCGEGMVCNNGE | 606 | Q9H2U9 | |
| AGIKCQVDRMSFPCG | 231 | Q9H175 | |
| CANGGQCLNRGPSRM | 411 | Q9NR61 | |
| GSVEKCPLCKGRGMQ | 146 | Q8WW22 | |
| CENMGACVRSPGSPQ | 1916 | Q9NYQ6 | |
| DMATGQCACKPGVIG | 2016 | Q9NYQ6 | |
| ADMCGVLQCKGGQQP | 546 | P78325 | |
| GPCAGQGEAGQKCMV | 806 | Q32M45 | |
| MNDQGKCLRGEGTCI | 196 | P26436 | |
| GGNSRNVCINGICKM | 661 | P58397 | |
| DGKVMQAPINGCRCE | 401 | Q9Y2G4 | |
| GPALCRGMERNSLGC | 6 | Q2M1V0 | |
| RGMERNSLGCCEAPK | 11 | Q2M1V0 | |
| DMKQRGGCPRGASCT | 421 | Q5TC82 | |
| VGGPGSGKTQVCLCM | 106 | O75771 | |
| LCDVPCSGDGTMRKN | 266 | Q08J23 | |
| DPLCGLCGNFNGNMK | 996 | Q6W4X9 | |
| LANPCQNGGSCMDGV | 916 | Q04721 | |
| LMKCGNGGTCIESGT | 2616 | Q5T1H1 | |
| GMQLLCGGLRHPNCM | 876 | P59045 | |
| MSCQISCKSRGRGGG | 1 | P35908 | |
| SCQGDSGGPLMCQEN | 966 | P98073 | |
| RDCNSLPGVMGTCKE | 106 | P54764 | |
| FGMGLVSGSKCPNNC | 16 | Q8N7C0 | |
| CGGPDSQIQRCNTDM | 4796 | Q96RW7 | |
| DLCPNGMTKAENGTC | 5256 | Q96RW7 | |
| DCDSLKGLCRIMGNG | 171 | Q86YD1 | |
| RFPCCRGSGKSNMGT | 31 | A0JP26 | |
| RNGGTCVVEKNGPMC | 2031 | Q5VYJ5 | |
| MNCLEGPGKTCGPLA | 1 | C9JE40 | |
| CTCVGAGDPRLAKMQ | 626 | Q92900 | |
| PLSCQNGGTCVNTMG | 181 | O60494 | |
| ECLPQAMNITCTGRG | 561 | P00533 | |
| AMNITCTGRGPDNCI | 566 | P00533 | |
| CVKTCPAGVMGENNT | 591 | P00533 | |
| MGQELCAKTVQPGCS | 1 | Q96Q40 | |
| GQKQSGSECICMSPE | 776 | P13671 | |
| KRGGGNEMNCCRTLR | 146 | Q5THR3 | |
| GAVCGLCGNMDRNPN | 4211 | Q9Y6R7 | |
| RDCNSMPGVLGTCKE | 106 | P29322 | |
| GCILGDEMGLGKTCQ | 66 | Q86WJ1 | |
| CGVMRGCGLAPSLSK | 41 | Q9NYD6 | |
| SGMCQRNPQVCGPGR | 546 | Q8N2S1 | |
| PASMSGSCGACINGK | 66 | Q8N7A1 | |
| SRPTSGKMNCDVCGL | 111 | Q9UKT9 | |
| KTGCPRRRNGMQGDC | 71 | Q504Y0 | |
| RFPCCKGSGKSNMGT | 31 | B2RU33 | |
| KPGTAMCVGCGSQIH | 21 | Q96A47 | |
| RFPCCRGSGKSNMGT | 31 | Q86YR6 | |
| DPGQMNDGPLCKCSA | 526 | Q9NRR4 | |
| SGGQKTARCACGGTM | 516 | Q9H8W5 | |
| NSCGAPMQGDDVLRC | 621 | Q8IYR2 | |
| CIGSCKGNTRLPGIM | 301 | O75602 | |
| CQGDSGGSLMCRNKK | 236 | Q7RTZ1 | |
| RAKMCGLGCAPSAGS | 531 | Q8IUH8 | |
| SNISCGNEKEPSMCG | 311 | Q53H47 | |
| GGAQRMPLCDKCGSG | 286 | Q53GG5 | |
| GSVLRGRMCVNCPLG | 991 | Q4LDE5 | |
| PCLCSVGRRGDGGKM | 21 | Q12769 | |
| RGCSNGGTCQLMPEK | 241 | Q99466 | |
| GKVLCACQVAQGAMP | 921 | Q5JTZ9 | |
| MAVPGCNKDSVRAGC | 1 | Q8N9Q2 | |
| AGQCGPVGVRKEMHC | 16 | P28702 | |
| QCEGPGMEIANCSRN | 581 | Q13591 | |
| TDCAKGQLSGQPLCM | 256 | P28329 | |
| NQRSGGPGCCQKRWM | 156 | Q6ZS10 | |
| SCRVCGGKHEPNMQL | 346 | Q96PU4 | |
| DPTCMNGGKCVGPST | 1491 | Q8N2E2 | |
| DCRGPMNQCLVATGT | 236 | Q03405 | |
| GACSPGARQGCMKSI | 1991 | P04275 | |
| NHNIPKGPCILCGMG | 301 | Q0ZLH3 | |
| KGPCILCGMGNFKRE | 306 | Q0ZLH3 | |
| MEACEDGGCQGPLKS | 56 | A6NEH6 | |
| GIVGRCQKDNGCPQM | 536 | Q9NYB5 | |
| SCNDCQQMIVKLGGG | 1121 | Q12772 | |
| MGELLQCGCQAPRGR | 126 | Q9Y6F9 | |
| RRMHPNVSQGCQGGC | 31 | Q9BXY4 | |
| QGRLCNKTSEGMDGC | 321 | P41221 | |
| GGCSTCGGCSPRMKV | 651 | Q9BZZ2 | |
| MSGRIPQAATCCGEK | 506 | Q96JE7 | |
| EKPMVCGECGRGFSQ | 491 | P52736 | |
| RMCPKAGDQTGGAFC | 101 | Q6ZTR6 | |
| KPLQRGIAACMTCGN | 2191 | Q9Y4A5 | |
| APMCKRRGGVGVATC | 631 | Q9NR64 | |
| NNMICAGLDRGQDPC | 211 | O43240 |